These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
19 Jun, 2026, 11.50 AM IST
L’Oréal buys control of Innovist as India beauty battle intensifiesL'Oréal SA is acquiring a majority stake in Indian beauty startup Innovist. This move strengthens L'Oréal's position in India's rapidly exp...
18 Jun, 2026, 12.49 PM IST
Haircare startup Xtovia raises Rs 6.9 crore led by V3 VenturesFounded in 2025 by entrepreneur Navneet Misra and Dr Tunga Madhu Babu, who heads research and development and holds a PhD from IIT Madras, ...
17 Jun, 2026, 03.28 PM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
17 Jun, 2026, 03.08 PM IST
Healthy hair starts with a healthy scalp: Why scalp care should be your first haircare stepWe spend a lot of time thinking about our hair: the right conditioner, the right oil, the right treatment. But the thing that actually dete...
16 Jun, 2026, 12.04 PM IST
Your shampoo may be cleaning your hair, but is it treating your scalp?Most shampoos do a decent job of cleaning the hair shaft. But if you keep dealing with flakes, an itchy scalp, or that persistent oily feel...
15 Jun, 2026, 05.46 PM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...
12 Jun, 2026, 12.49 PM IST
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
12 Jun, 2026, 12.25 PM IST
Hexagon Nutrition shares list at 7% premium over IPO price on boursesHexagon Nutrition debuted at a premium of up to 7.2% over its IPO price, in line with grey market expectations. The Rs 138.9 crore issue wa...
12 Jun, 2026, 11.32 AM IST
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
09 Jun, 2026, 08.48 PM IST
A new-age thirst for beverages is emerging as a key force in India's consumer goods marketBeverage industry in India: Indian companies are seeing strong growth in drinks like coffee, ready-to-drink options, and protein beverages....
09 Jun, 2026, 07.42 PM IST
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
09 Jun, 2026, 07.34 PM IST
Iran war: Fuel price surge squeezes dairy, poultry value chainsIndustry officials say rising fuel costs, coupled with geopolitical disruptions affecting commodity markets, are squeezing farmer margins a...
09 Jun, 2026, 11.31 AM IST
Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
08 Jun, 2026, 02.25 PM IST
Hexagon Nutrition IPO Day 2: GMP signals 15% listing gain; Retail portion subscribed 2.43xHexagon Nutrition’s Rs 139 crore IPO saw strong retail demand on Day 2, with the retail portion subscribed 2.43 times. The grey market prem...
08 Jun, 2026, 10.23 AM IST
Hexagon Nutrition IPO Day 1: 37% subscription, Grey market signals 27% listing gainHexagon Nutrition's IPO opened strongly on its first day. Retail investors showed significant interest, subscribing 62% of their quota. The...
05 Jun, 2026, 12.18 PM IST
Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
03 Jun, 2026, 09.22 AM IST